Form 4 for BIAF bioAffinity Technologies, Inc.
Accepted 2023-07-06 00:00:00 ET · period of report 2023-06-06 · accession 0001493152-23-023818 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 2023-07-06 | 2023-06-06 | BIAF | Dougherty Michael Philip | CFO | A - Grant | $1.91 | +52.4K | 52.4K | New | +$100.0K |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2023-06-06 | A | A | 52,356 | $1.91 | 52,356 | D | — | — | (F1) Represents a grant from bioAffinity Technologies, Inc. (the "Company") to Mr. Dougherty of 52,356 shares of common stock, par value $0.007, pursuant to the terms of an employment offer letter dated April 11, 2023, which was approved by the Board of Directors of the Company on May 11, 2023. |